Hamostaseologie 2019; 39(S 01): S1-S92
DOI: 10.1055/s-0039-1680229
Georg Thieme Verlag KG Stuttgart · New YorkProphylaxis with Extended Dosing of BAY94-9027 Decreases Overall and Joint Bleeding
Rates with Consistent Consumption for Over 4 Years of Treatment
Authors
-
I. Pabinger
1
Medical University of Vienna, Vienna, Austria
-
J. Oldenburg
2
University Clinic Bonn, Bonn, Germany
-
A. Huth-Kuhne
3
SRH Kurpfalzkrankenhaus Heidelberg GmbH, Heidelberg, Germany
-
T. Liu
4
Bayer AG, Berlin, Germany
-
M. Enriquez Maas
5
Bayer AG, Wuppertal, Germany